Clinical Trial

Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation

Study acronym: RESET
Recruiting
View on ClinicalTrials.gov →
Summary
This is a study for hypersensitized patients who have been waiting for more than 3 years for an offer for a kidney transplant. The objective is to perform a transplant of autologous hematopoietic precursors with the aim of producing what we call an immunological reset to make the maximum number of anti-HLA antibodies disappear and thus increase the chances of the patient receiving an offer for a kidney transplant.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-04.
Trial Details
NCT Number NCT06809075
Lead Sponsor Hospital Universitari Vall d'Hebron Research Institute
Conditions Kidney Disease, Kidney Transplant, Kidney Transplant Candidates
Enrollment 10 participants
Start Date 2024-04-05
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-12